Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? - PubMed (original) (raw)
Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?
F Licastro et al. J Neuroimmunol. 2000.
Free article
Abstract
Plasma concentrations of interleukin-1beta (IL-1beta), interleukin-6 (IL-6), C reactive protein (CRP) and alpha-1-antichymotrypsin (ACT) in 145 patients with probable Alzheimer's disease (AD) and 51 non-demented controls were measured. To investigate the cellular activation of peripheral immune system, plasma levels of neopterin were also investigated. Plasma levels of IL-1 were detectable in 17 patients with AD (13%) and only in one control (2%) and average levels of IL-1 were higher in AD patients than in controls (p < 0.001). IL-6 plasma levels were detectable in a higher proportion of AD and controls (53% and 27%, respectively), and were increased in patients with AD (p < 0.001). Plasma levels of ACT were increased in patients with AD (p < 0.001) and CRP levels were in the normal range. Plasma levels of neopterin were slightly lower in AD patients than in controls, but differences were not statistically significant. No significant correlation was observed between IL-1 and IL-6 levels or neopterin and cytokine levels in plasma from AD patients. Plasma levels of ACT negatively correlated with cognitive performances, as assessed by the mini mental state examination (MMSE; R = -0.26, p < 0.02) and positively correlated with the global deterioration state (GDS) of AD patients (R = 0.30, p < 0.007). Present findings suggested that detectable levels of circulating cytokines and increased ACT might not be derived by activation of peripheral immune system of AD patients. Detection of these molecules might be used for monitoring the progression of brain inflammation associated with AD.
Similar articles
- Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.
Licastro F, Pedrini S, Ferri C, Casadei V, Govoni M, Pession A, Sciacca FL, Veglia F, Annoni G, Bonafè M, Olivieri F, Franceschi C, Grimaldi LM. Licastro F, et al. Ann Neurol. 2000 Sep;48(3):388-91. Ann Neurol. 2000. PMID: 10976648 - Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response.
Licastro F, Morini MC, Polazzi E, Davis LJ. Licastro F, et al. J Neuroimmunol. 1995 Mar;57(1-2):71-5. doi: 10.1016/0165-5728(94)00163-i. J Neuroimmunol. 1995. PMID: 7535791 - Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD. Lanzrein AS, et al. Alzheimer Dis Assoc Disord. 1998 Sep;12(3):215-27. doi: 10.1097/00002093-199809000-00016. Alzheimer Dis Assoc Disord. 1998. PMID: 9772027 - IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis.
Ng A, Tam WW, Zhang MW, Ho CS, Husain SF, McIntyre RS, Ho RC. Ng A, et al. Sci Rep. 2018 Aug 13;8(1):12050. doi: 10.1038/s41598-018-30487-6. Sci Rep. 2018. PMID: 30104698 Free PMC article. Review. - Is there an association between peripheral immune markers and structural/functional neuroimaging findings?
Frodl T, Amico F. Frodl T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:295-303. doi: 10.1016/j.pnpbp.2012.12.013. Epub 2013 Jan 11. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 23313563 Review.
Cited by
- Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China.
Zhu Y, Tan Z, Li S, Zhu F, Qin C, Zhang Q, Yang Y. Zhu Y, et al. Front Aging Neurosci. 2022 Sep 9;14:919430. doi: 10.3389/fnagi.2022.919430. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36158553 Free PMC article. - Interleukin-1 beta and neurotrophin-3 synergistically promote neurite growth in vitro.
Boato F, Hechler D, Rosenberger K, Lüdecke D, Peters EM, Nitsch R, Hendrix S. Boato F, et al. J Neuroinflammation. 2011 Dec 26;8:183. doi: 10.1186/1742-2094-8-183. J Neuroinflammation. 2011. PMID: 22200088 Free PMC article. - Increased inflammation in BA21 brain tissue from African Americans with Alzheimer's disease.
Ferguson SA, Varma V, Sloper D, Panos JJ, Sarkar S. Ferguson SA, et al. Metab Brain Dis. 2020 Jan;35(1):121-133. doi: 10.1007/s11011-019-00512-2. Epub 2019 Dec 10. Metab Brain Dis. 2020. PMID: 31823110 - Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients.
Wang R, Ross CA, Cai H, Cong WN, Daimon CM, Carlson OD, Egan JM, Siddiqui S, Maudsley S, Martin B. Wang R, et al. Front Physiol. 2014 Jun 23;5:231. doi: 10.3389/fphys.2014.00231. eCollection 2014. Front Physiol. 2014. PMID: 25002850 Free PMC article. - Photobiomodulation for the treatment of neuroinflammation: A systematic review of controlled laboratory animal studies.
Cardoso FDS, Salehpour F, Coimbra NC, Gonzalez-Lima F, Gomes da Silva S. Cardoso FDS, et al. Front Neurosci. 2022 Sep 20;16:1006031. doi: 10.3389/fnins.2022.1006031. eCollection 2022. Front Neurosci. 2022. PMID: 36203812 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous